HeraMED Limited (ASX:HMD), has announced the “soft launch” of HeraCARE within the Telstra Health ecosystem through targeted GP clinics.
In November 2023, HeraMED announced its partnership with Telstra Health’s MedicalDirector platform servicing GP and healthcare professionals as the first remote maternity solution to join the Telstra Health digital ecosystem.
The medical data and technology company, which is focused on the digital transformation of maternity care, said the initial commercial rollout will see the first group of GP clinics integrated into HeraCARE’s MedicalDirector, GP workflows,before a full launch to the larger network.
On completion of the soft launch, HeraMED anticipates a marketing expansion through Telstra Health’s GP clinics practices by the end of the 2024 calendar year.
HeraMED and Telstra Health will also jointly promote the integration of HeraMED into the Smart Connected Care ecosystem through education and marketing to existing and prospective users as part of the Smart Partner Marketing Plan.
In 2022-2023, there were around 166 million GP patient encounters in Australia. According to the Royal Australian College of General Practitioners (RACGP). RACGP, pregnancy-related problems account for 2.7% of all GP–patient encounters, and of these encounters, 89.8% are for pregnancy or antenatal care.
HeraMED CEO Anoushka Gungadin commented: “HeraCARE is a mum-centric solution and the partnership with Telstra Health allows us to expand access to care for many more mums, given the significant role GPs play in maternity, pregnancy and postpartum care.
“Following integration and commercial rollout within this new ecosystem, we are targeting the onboarding of mums through GP practices by the end of calendar year 2024.
“This aligns with the four-point plan both for commercialisation and strategic partnership while redefining how maternity care is delivered and experienced.”
HMD was trading nearly 4% up at 2.8 cents.